Showing results (51-60 of 73) with videos related to

Sort By:
Pageof 8
Nature Communications|December 2, 2022
Prior exposure to B. pertussis shapes the mucosal antibody response to acellular pertussis booster vaccinationEvi van Schuppen, Janeri Fröberg, Prashanna Balaji Venkatasubramanian, et al.
Plos One|March 3, 2026
Class switching toward IgG4 six months after primary mRNA-based COVID-19 vaccination in kidney patientsSophie C Frölke, Kenney G Amirkhan, Nelly van der Bom-Baylon, et al.
Nature Communications|March 8, 2024
Antiviral responses induced by Tdap-IPV vaccination are associated with persistent humoral immunity to Bordetella pertussisJoshua Gillard, Madeleine Suffiotti, Peter Brazda, et al.
Ebiomedicine|March 1, 2021
Responses to an acellular pertussis booster vaccination in children, adolescents, and young and older adults: A collaborative study in Finland, the Netherlands, and the United KingdomPauline Versteegen, Marta Valente Pinto, Alex M Barkoff, et al.
Plos One|August 22, 2020
Effect of FHA and Prn on Bordetella pertussis colonization of mice is dependent on vaccine type and anatomical siteAnne Zeddeman, Evi van Schuppen, Kristianne E Kok, et al.
The Lancet. Microbe|January 10, 2026
Mucosal immune responses to Bordetella pertussis in Gambian infants after maternal and primary vaccination: an immunological substudy of a single-centre, randomised, controlled, double-blind, phase 4 trialAnja Saso, Janeri Fröberg, Haddijatou Jobe, et al.
NPJ Vaccines|February 18, 2022
BCG-induced trained immunity enhances acellular pertussis vaccination responses in an explorative randomized clinical trialJoshua Gillard, Bastiaan A Blok, Daniel R Garza, et al.
Scientific Reports|May 31, 2022
SARS-CoV-2 RNA in exhaled air of hospitalized COVID-19 patientsLisa Kurver, Corné H van den Kieboom, Kjerstin Lanke, et al.
The Lancet. Microbe|March 26, 2026
Safety, colonisation kinetics, transmissibility, and immune correlates of protection in healthy adults inoculated with Bordetella pertussis in England: a single-centre, open-label, phase 1, controlled human infection studyHans de Graaf, Diane F Gbesemete, Alison R Hill, et al.
Virulence|October 5, 2020
Exploring metal availability in the natural niche of Streptococcus pneumoniae to discover potential vaccine antigensLucille F van Beek, Kristin Surmann, H Bart van den Berg van Saparoea, et al.
Pageof 8